Spyre Therapeutics Inc logo

Spyre Therapeutics Inc Share Price Today (NASDAQ: SYRE)

Spyre Therapeutics Inc share price is 15.2 & ₹1,301.80 as on 17 May 2025, 2.30 'hrs' IST

$15.2

0.66

(4.54%)

Market is closed - opens 7 PM, 19 May 2025

View live Spyre Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Spyre Therapeutics Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Spyre Therapeutics Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Spyre Therapeutics Inc share price movements

  • Today's Low: $14.97
    Today's High: $15.31

    Day's Volatility :2.19%

  • 52 Weeks Low: $10.91
    52 Weeks High: $40.26

    52 Weeks Volatility :72.9%

Spyre Therapeutics Inc (SYRE) Returns

PeriodSpyre Therapeutics IncIndex (Russel 2000)
3 Months
-31.13%
0.0%
6 Months
-46.98%
0.0%
1 Year
-58.77%
0.0%
3 Years
-59.47%
-0.4%

Spyre Therapeutics Inc (SYRE) Key Statistics

in dollars & INR

Previous Close
$14.54
Open
$14.97
Today's High
$15.305
Today's Low
$14.97
Market Capitalization
$916.2M
Today's Volume
$340.7K
52 Week High
$40.26
52 Week Low
$10.91
Revenue TTM
$0.0
EBITDA
$-207.8M
Earnings Per Share (EPS)
$-3.06
Profit Margin
0.0%
Quarterly Earnings Growth YOY
-1.0%
Return On Equity TTM
-65.82%

How to invest in Spyre Therapeutics Inc Stock (SYRE) from India?

It is very easy for Indian residents to invest directly in Spyre Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Spyre Therapeutics Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Spyre Therapeutics Inc or SYRE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Spyre Therapeutics Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Spyre Therapeutics Inc shares which would translate to 0.056 fractional shares of Spyre Therapeutics Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Spyre Therapeutics Inc, in just a few clicks!

Returns in Spyre Therapeutics Inc (SYRE) for Indian investors in Rupees

The Spyre Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Spyre Therapeutics Inc investment value today

Current value as on today

₹43,957

Returns

₹56,043

(-56.04%)

Returns from Spyre Therapeutics Inc Stock

₹58,774 (-58.77%)

Dollar Returns

₹2,731 (+2.73%)

Indian investors sentiment towards Spyre Therapeutics Inc (SYRE)

-25%

Period: Apr 18, 2025 to May 18, 2025. Change in 30 Days versus previous period

Search interest for Spyre Therapeutics Inc Stock from India on INDmoney has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Spyre Therapeutics Inc

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Spyre Therapeutics Inc(by analysts ranked 0 to 5 stars)

Insights on SYRE Stock (Ticker Symbol: SYRE)

  • Price Movement

    In the last 3 months, SYRE stock has moved down by -32.1%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 168.0K → 1.04M (in $), with an average increase of 40.1% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -69.02M → -44.77M (in $), with an average increase of 24.2% per quarter
  • SYRE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 90.9% return, outperforming this stock by 150.7%
  • SYRE vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 120.4% return, outperforming this stock by 180.1%

Spyre Therapeutics Inc (SYRE) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Spyre Therapeutics Inc logo
12.01%
-46.98%
-58.77%
-59.47%
-92.87%
Regeneron Pharmaceuticals, Inc. logo
5.81%
-22.03%
-39.82%
-10.14%
2.98%
Beone Medicines Ltd logo
-0.51%
21.5%
30.82%
66.06%
37.54%
Vertex Pharmaceuticals Incorporated logo
-8.14%
-6.07%
-1.62%
69.63%
54.11%
Alnylam Pharmaceuticals, Inc. logo
22.5%
22.76%
89.78%
115.57%
98.77%

About Spyre Therapeutics Inc

Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human monoclonal immunoglobulin G1 antibody designed to bind selectively to the a4ß7 integrin being developed for the treatment of IBD (ulcerative colitis and Crohn's disease). The company is developing SPY002, a human monoclonal antibody (mAb)candidates designed to bind to tumor necrosis factor-like ligand 1A; and SPY120, a combination of SPY001 (anti-a4ß7) and SPY002 (anti-TL1A) antibodies, which are in preclinical studies. In addition, its other early-stage programs include SPY003, an anti-IL-23 mAb; SPY004; SPY130, a combination of anti-a4ß7 and anti-IL-23 mAbs; and SPY230, a combination of anti-TL1A and anti-IL-23 mAbs. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. The company was incorporated in 2013 and is based in Waltham, Massachusetts.
Organization
Spyre Therapeutics Inc
Employees
73
CEO
Dr. Cameron Turtle DPHIL, Ph.D.
Industry
Miscellaneous

Management People of Spyre Therapeutics Inc

NameTitle
Dr. Cameron Turtle DPHIL, Ph.D.
CEO & Director
Mr. Scott L. Burrows
Chief Financial Officer
Dr. Sheldon Sloan M.B.E., M.D.
Chief Medical Officer
Dr. Janet Gunzner-Toste M.B.A., Ph.D.
Senior Vice President of Operations
Mr. Brian Connolly
Chief Technical Officer
Mr. Eric McIntyre
Vice President of Finance & Investor Relations
Ms. Heidy Abreu King-Jones J.D., L.L.M.
Chief Legal Officer & Corporate Secretary
Mr. James Myers
Vice President of Quality & Compliance
Dr. Justin LaFountaine Ph.D.
Senior Vice President of Corporate Development
Ms. Melissa Cooper
Senior Vice President of People

Important FAQs about investing in SYRE Stock from India :

Can Indians buy Spyre Therapeutics Inc shares?

Yes, Indians can invest in the Spyre Therapeutics Inc (SYRE) from India.

With INDmoney, you can buy Spyre Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Spyre Therapeutics Inc at zero transaction cost.

How can I buy Spyre Therapeutics Inc shares from India?

It is very easy to buy Spyre Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Spyre Therapeutics Inc (SYRE) be purchased?

Yes, you can buy fractional shares of Spyre Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Spyre Therapeutics Inc stocks?

To start investing in Spyre Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Spyre Therapeutics Inc share price today?

Spyre Therapeutics Inc share price today stands at $15.20, Open: $14.97 ; Previous Close: $14.54 ; High: $15.31 ; Low: $14.97 ; 52 Week High: $40.26 ; 52 Week Low: $10.91.

The stock opens at $14.97, after a previous close of $14.54. The stock reached a daily high of $15.31 and a low of $14.97, with a 52-week high of $40.26 and a 52-week low of $10.91.

What are today’s High and Low prices of Spyre Therapeutics Inc Stock (SYRE)?

Today’s highest price of Spyre Therapeutics Inc (SYRE) is $15.31.

Today’s lowest price of Spyre Therapeutics Inc (SYRE) is $14.97.

What is the 52 Week High and Low Range of Spyre Therapeutics Inc Stock (SYRE)?

  • 52 Week High

    $40.26

  • 52 Week Low

    $10.91

What are the historical returns of Spyre Therapeutics Inc (SYRE)?

  • 1 Month Returns

    12.01%

  • 3 Months Returns

    -46.98%

  • 1 Year Returns

    -58.77%

  • 5 Years Returns

    -92.87%

What is today's market capitalisation of Spyre Therapeutics Inc?

Today's market capitalisation of Spyre Therapeutics Inc SYRE is 916.2M

Who is the Chief Executive Officer (CEO) of Spyre Therapeutics Inc ?

Dr. Cameron Turtle DPHIL, Ph.D. is the current Chief Executive Officer (CEO) of Spyre Therapeutics Inc.